Cargando…

Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration

INTRODUCTION: In cost-effectiveness analyses, the future costs, disutility and mortality from alternative causes of morbidity are often not completely taken into account. We explored the impact of different assumed values for each of these factors on the cost-effectiveness of screening for colorecta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omidvari, Amir-Houshang, Lansdorp-Vogelaar, Iris, de Koning, Harry J., Meester, Reinier G. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274850/ https://www.ncbi.nlm.nih.gov/pubmed/34252090 http://dx.doi.org/10.1371/journal.pone.0253893

Ejemplares similares

Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests
por: Peterse, Elisabeth F P, et al.
Publicado: (2020)

Cost-Effectiveness of Colonoscopy-Based Colorectal Cancer Screening in Childhood Cancer Survivors
por: Gini, Andrea, et al.
Publicado: (2019)

The impact of pancreatic cancer screening on life expectancy: A systematic review of modeling studies
por: Koopmann, Brechtje D. M., et al.
Publicado: (2022)

Better Informing Decision Making with Multiple Outcomes Cost-Effectiveness Analysis under Uncertainty in Cost-Disutility Space
por: McCaffrey, Nikki, et al.
Publicado: (2015)

Cost-effectiveness of Colorectal Cancer Screening
por: Lansdorp-Vogelaar, Iris, et al.
Publicado: (2011)

Cost‐effectiveness of surveillance schedules in older adults with non‐muscle‐invasive bladder cancer
por: Heijnsdijk, Eveline A.M., et al.
Publicado: (2018)

The Optimal Age to Stop Endoscopic Surveillance of Patients With Barrett’s Esophagus Based on Sex and Comorbidity: A Comparative Cost-Effectiveness Analysis
por: Omidvari, Amir-Houshang, et al.
Publicado: (2021)

Risk‐stratified strategies in population screening for colorectal cancer
por: Lansdorp‐Vogelaar, Iris, et al.
Publicado: (2021)

An Evolutionary Algorithm to Personalize Stool-Based Colorectal Cancer Screening
por: van Duuren, Luuk A., et al.
Publicado: (2022)

Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model
por: Arrospide, Arantzazu, et al.
Publicado: (2018)

Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018
por: Meester, Reinier G S, et al.
Publicado: (2015)

652: IMPACT AND RECOVERY FROM COVID-19-RELATED DISRUPTIONS IN COLORECTAL CANCER SCREENING AND CARE: A SCENARIO ANALYSIS
por: Puttelaar, Rosita van den, et al.
Publicado: (2022)

Impact and Recovery from COVID-19–Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis
por: van den Puttelaar, Rosita, et al.
Publicado: (2023)

Disutility associated with cancer screening programs: A systematic review
por: Li, Lin, et al.
Publicado: (2019)

Disutility Study for Adult Patients with Moderate to Severe Crohn’s Disease
por: Worbes-Cerezo, Melany, et al.
Publicado: (2019)

Cost-effectiveness analysis of colorectal cancer screening in a low incidence country: The case of Saudi Arabia
por: Naber, Steffie K., et al.
Publicado: (2021)

Cost-effectiveness analysis of colorectal cancer screening in Shanghai, China: A modelling study
por: Wang, Jie, et al.
Publicado: (2022)

Bias in energy system models with uniform cost of capital assumption
por: Egli, Florian, et al.
Publicado: (2019)

Reply to ‘Bias in energy system models with uniform cost of capital assumption’
por: Bogdanov, Dmitrii, et al.
Publicado: (2019)

The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline
por: Peterse, Elisabeth F. P., et al.
Publicado: (2018)

Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population
por: Cenin, Dayna R, et al.
Publicado: (2018)

It is not always about gains: utilities and disutilities associated with treatment features in patients with moderate-to-severe psoriasis
por: Umar, Nasir, et al.
Publicado: (2012)

Instrumental variable specifications and assumptions for longitudinal analysis of mental health cost offsets
por: O’Malley, A. James
Publicado: (2012)

Improving inference for aerial surveys of bears: The importance of assumptions and the cost of unnecessary complexity
por: Schmidt, Joshua H., et al.
Publicado: (2017)

Quantifying the impact of taking medicines for primary prevention: a time-trade off study to elicit direct treatment disutility in the UK
por: Thompson, Alexander, et al.
Publicado: (2023)

Cost‐effectiveness of prophylactic hysterectomy in first‐degree female relatives with Lynch syndrome of patients diagnosed with colorectal cancer in the United States: a microsimulation study
por: Alblas, Maaike, et al.
Publicado: (2021)

Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries
por: Naber, Steffie K., et al.
Publicado: (2019)

Whether and How Disutilities of Adverse Events were Used in the Economic Evaluation of Drug Therapy for Cancer Treatment
por: Lu, Yuqiong, et al.
Publicado: (2023)

Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future Potential
por: Naber, Steffie K, et al.
Publicado: (2019)

Disutility of injectable therapies in obesity and type 2 diabetes mellitus: general population preferences in the UK, Canada, and China
por: McEwan, Phil, et al.
Publicado: (2022)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
por: Goede, S. Lucas, et al.
Publicado: (2017)

Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model
por: Meester, Reinier G S, et al.
Publicado: (2023)

Simulation modeling for stratified breast cancer screening – a systematic review of cost and quality of life assumptions
por: Arnold, Matthias
Publicado: (2017)

Colorectal Cancer Screening in the Novel Coronavirus Disease-2019 Era
por: Dekker, Evelien, et al.
Publicado: (2020)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
por: Goede, S Lucas, et al.
Publicado: (2013)

The impact of assumptions regarding vaccine-induced immunity on the public health and cost-effectiveness of hepatitis A vaccination: Is one dose sufficient?
por: Curran, Desmond, et al.
Publicado: (2016)

Estimating utilities/disutilities for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and treatment-related adverse events
por: Hall, F., et al.
Publicado: (2019)

Disease control programme support costs: an update of WHO-CHOICE methodology, price databases and quantity assumptions
por: Bertram, Melanie Y., et al.
Publicado: (2017)

Future Costs in Cost-Effectiveness Analyses: Past, Present, Future
por: de Vries, Linda M., et al.
Publicado: (2018)

Prenatal Substance Use: Exploring Assumptions of Maternal Unfitness
por: Terplan, Mishka, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7pr9jm5na2jlhsj6qutd0v2ll8